InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Silvernail Lauren P, Executive. Insider active across 4 companies, notably Evolus, Inc.. Cumulatively, 12 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €577k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Silvernail Lauren P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
10,075 sharesCommon Stock - Restricted Stock UnitsSEC:0001225755-26-000002:0
1,439 shares0Common StockSEC:0001029142-25-000106:0
5,000 sharesCommon StockSEC:0000950170-24-029447:0
5,000 shares0Common StockSEC:0001209191-23-056799:0
16,189 shares@ US$13.920248.4% of flowCommon StockSEC:0001570562-22-000107:0
10,192 shares@ US$9.725420.7% of flowCommon StockSEC:0001570562-22-000083:0
53,571 shares0Common StockSEC:0001570562-22-000054:0
14,293 shares@ US$11.178530.9% of flowCommon StockSEC:0001570562-21-000156:0
14,293 shares@ US$11.17850.032% mcap16.0% of flowCommon StockSEC:0001570562-21-000158:0
10,000 sharesCommon StockSEC:0001209191-16-095725:0
1,063 sharesCommon StockSEC:0001209191-16-094531:0
339 sharesCommon StockSEC:0001209191-16-088106:0
12 of 12 declarations
About Silvernail Lauren P
SILVERNAIL LAUREN P is Dirigeant. They are associated with Evolus, Inc., Revance Therapeutics, Inc., Dynavax Technologies CORP and Harpoon Therapeutics, Inc. The record shows 12 filings in total, and across the 12 sampled filings, the cumulative sell volume is EUR 577451, with the modal transaction nature listed as Attribution, over the period from 2016-01-04 to 2026-02-10.
